» Articles » PMID: 21262433

Thrombin Generation Tests

Overview
Journal Thromb Res
Date 2011 Jan 26
PMID 21262433
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

The recent development of semi-automated methods has revived interest in the thrombin generation test, a global assay that measures the overall tendency of a plasma sample to form thrombin after initiation of coagulation. The thrombin generation curve, which is characterised by a lag phase followed by the formation and subsequent inhibition of thrombin, reflects all three phases of coagulation (initiation, propagation and termination). However, the specific contribution of each coagulation factor or inhibitor to the assay outcome depends on the reaction conditions used (e.g. tissue factor concentration used to trigger coagulation, addition of thrombomodulin or activated protein C). Although several studies have shown a correlation between thrombin generation and the risk of bleeding or venous thrombosis, the application of thrombin generation assays to clinical decision-making is still hampered by standardisation problems. The present paper discusses these issues with particular reference to Calibrated Automated Thrombography.

Citing Articles

Increased thrombin generation in kidney transplant recipients with donor-specific antibodies directed against human leukocyte antigens.

Loczi L, P Szabo R, Orban-Kalmandi R, Hodossy-Takacs R, Szilvasi A, Szalai Z Front Immunol. 2024; 15:1407407.

PMID: 39524447 PMC: 11543428. DOI: 10.3389/fimmu.2024.1407407.


Elevated thrombin generation levels in the left atrial appendage in patients with atrial fibrillation.

Elias A, Khoury Y, Shehadeh F, Ron G, Boulos M, Nashashibi J Res Pract Thromb Haemost. 2023; 7(2):100127.

PMID: 37063762 PMC: 10099305. DOI: 10.1016/j.rpth.2023.100127.


Application of the thrombin generation assay in patients with antiphospholipid syndrome: A systematic review of the literature.

Gehlen R, Vandevelde A, de Laat B, Devreese K Front Cardiovasc Med. 2023; 10:1075121.

PMID: 37057100 PMC: 10089302. DOI: 10.3389/fcvm.2023.1075121.


Evaluation of Haemostasis in Dogs Affected by Resectable Malignancy.

Bruno B, Maurella C, Gianella P, Mengozzi G, Ferraris E, Borrelli A Animals (Basel). 2023; 13(1).

PMID: 36611772 PMC: 9817527. DOI: 10.3390/ani13010164.


Assessing the individual roles of FII, FV, and FX activity in the thrombin generation process.

Bai C, Konings J, Ninivaggi M, Lance M, de Laat B, de Laat-Kremers R Front Cardiovasc Med. 2022; 9:1000812.

PMID: 36204573 PMC: 9530111. DOI: 10.3389/fcvm.2022.1000812.